XBiotech (XBIT) Exchange Rate Effect (2014 - 2023)
XBiotech (XBIT) posted quarterly Exchange Rate Effect of $1.4 million for Q4 2023, down 63.77% year-over-year from $3.8 million in Q4 2022, and up 189.38% quarter-over-quarter from -$1.5 million in Q3 2023.
XBiotech (XBIT) Exchange Rate Effect (2014 - 2023) Analysis & Trends
XBiotech's Exchange Rate Effect history runs 10 years deep, the most recent figure standing at $1.4 million for Q4 2023.
- In Q4 2023, Exchange Rate Effect fell 63.77% year-over-year to $1.4 million; the TTM figure through Dec 2023 stood at -$46000.0 (up 95.21% YoY), while the FY2025 annual figure was $3.3 million, up 160.28% from the prior year.
- Exchange Rate Effect for Q4 2023 stood at $1.4 million, up from -$1.5 million in the prior quarter.
- The five-year high for Exchange Rate Effect was $3.8 million in Q4 2022, with the low at -$4.3 million in Q3 2022.
- The 5-year median for Exchange Rate Effect is $106000.0 (2020), against an average of $60950.0.
- The sharpest annual moves came in 2019 and 2022: Exchange Rate Effect surged 1871.43% in 2019, then slumped 1705.42% in 2022.
- XBiotech's Exchange Rate Effect stood at -$164000.0 in 2019, then surged by 1132.93% to $1.7 million in 2020, then slumped by 81.82% to $308000.0 in 2021, then soared by 1136.69% to $3.8 million in 2022, then slumped by 63.77% to $1.4 million in 2023.
- Business Quant data shows XBIT's Exchange Rate Effect at $1.4 million in Q4 2023, -$1.5 million in Q3 2023, and $126000.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -2.45 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -287,000.00 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.63 Mn |
| 10 | XBiotech | 68.90 Mn | 68.90 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 1.38 Mn |
| Dec 31, 2023 | 1.38 Mn |
| Sep 30, 2023 | -1.54 Mn |
| Sep 30, 2023 | -1.54 Mn |
| Jun 30, 2023 | 126,000.00 |
| Jun 30, 2023 | 126,000.00 |
| Mar 31, 2023 | -8,000.00 |
| Mar 31, 2023 | -8,000.00 |
| Dec 31, 2022 | 3.81 Mn |
| Dec 31, 2022 | 3.81 Mn |
| Sep 30, 2022 | -4.33 Mn |
| Sep 30, 2022 | -4.33 Mn |
| Jun 30, 2022 | -559,000.00 |
| Jun 30, 2022 | -559,000.00 |
| Mar 31, 2022 | 122,000.00 |
| Mar 31, 2022 | 122,000.00 |
| Dec 31, 2021 | 308,000.00 |
| Dec 31, 2021 | 308,000.00 |
| Sep 30, 2021 | -240,000.00 |
| Sep 30, 2021 | -240,000.00 |